Dr. Shaywitz trained in internal medicine and endocrinology at MGH, and conducted his post-doctoral research in the Melton lab at Harvard. He gained experience in early clinical drug development in the Department of Experimental Medicine at Merck, then joined the Boston Consulting Group’s Healthcare and Corporate Development practices, where he focused on strategy and organizational design. He is currently Director of Strategic and Commercial Planning at Theravance, a publicly-held drug development company in South San Francisco. He recently wrote Tech Tonics: Can Passionate Entreprenuers Heal Healthcare With Technology?
Ph.D., Biology, M.I.T.
M.D., Health Sciences & Technology Program, Harvard Medical School/M.I.T.
A.B., summa cum laude, Biochemistry, Harvard College
While the deficiencies of our current healthcare system have been widely discussed and exhaustively lamented, it’s refreshing and instructive to see how these challenges look through the eyes of a seasoned entrepreneur.
The rise in U.S. health-care costs, to nearly 18% of GDP today from around 6% of GDP in 1965, has alarmed journalists, inspired policy wonks and left patients struggling to find empathy in a system that tends to view them as "a vessel for billing codes," as the technologist Dave Chase has put it.
While humility may not be a quality we associated with either great artists or corporate titans, it emerges as one of the most important themes of Catmull’s book. It’s a profound, deep humility, one resulting from a thoughtful, introspective consideration of the uncertainties and contingencies of life and business.
I’ve long wished Microbe Hunters could be updated in a way that more fully contextualizes the researchers’ work and achievements. In reading Thomas Goetz’s The Remedy this weekend, I felt that my wish was finally granted.
When providing care and offering advice, should a physician think only of the patient in front of her, or does she have an obligation to balance the needs of the individual patient with the broader needs of society?